Medicare Part B Premiums Poised for Sharp Increase in 2026 Following 2024 Asset Sale Microsoft and Anthropic in Talks for Custom AI Chip Supply Deal PutinXi Talks Set to Revive Power of Siberia 2 Gas Pipeline Amid Energy Market Turmoil Arabica Coffee Prices Hit Record as USColombia Tariff Threat Withdrawn US Stock Futures Decline as Bond Yields Fall Following Reports of Putins Updated Nuclear Doctrine Amazon Launches AI Shopping Technology for Retailers Signs Kate Spade as First Customer TSCO Q1 2026 Earnings EPS Miss Sends Stock Lower Amid Cost Pressures Culp Inc CULP Q1 2026 Earnings WiderThanExpected Loss Sends Stock Lower Magna International Inc MGA Q1 2026 Earnings EPS Blows Past Estimates Stock Gains 236 ORN Q1 2026 Earnings EPS Surprises to the Positive Stock Rises TGE Value Creative Solutions Corp BEBE Q3 2016 Earnings Significant EPS Miss Amidst Challenging Quarter SNOW Q1 2026 Earnings Earnings Beat Drives Stock Higher Amidst Uncertainty on Revenue Snail Inc SNAL Nears Support Level Amid Continued Selling Pressure Aditxt Inc ADTX Plunges 1957 Key Support Level Tested at 019 Happy City Holdings HCHL Edges Lower Tests Support Zone Near 340 Launch One Acquisition Corp LPAA Holds Steady Near 1077 as Support Levels Firm Protalix BioTherapeutics PLX Holds Steady Above Support Key Levels to Watch PZZA Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment Hut 8 Corp Q3 2024 Earnings EPS beats estimates as company navigates Bitcoin mining headwinds Gloo Holdings Inc GLOO Q4 2025 Earnings Net Loss of 078 per Share Stock Declines 26 Sphere 3D Corp ANY Q4 2025 Earnings NarrowerThanExpected Loss Amidst Strategic Transition Carscom Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Union Bank Board Approves Up to Rs 8000 Crore Fundraising via Equity and Debt SKIL Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher Sabesp SBS Edges Lower Analyzing Support and Resistance Levels Amidst Modest Decline CISS Q3 2025 Earnings Operating Loss Deepens Shares Slide XCUR Q2 2022 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue HTZ Q1 2026 Earnings Narrower Loss Beats Estimates Amid Ongoing Operational Challenges MRNA Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Hub Group HUBG Q3 2025 Earnings EPS Falls Just Below Consensus Shares Edge Higher YSG Q4 2025 Earnings Positive EPS but Revenue Transparency Remains Limited Telomir Pharmaceuticals TELO Q4 2025 Earnings WiderthanExpected Loss Amid Ongoing Development